Company intelligence / Profile preview

SUPERFARMA

Ownership: Private
Development stage: Commercial

Overview

Super-Pharm is Israel’s largest pharmacy chain with international operations. In 2023, it acquired 50% of Hy Laboratories Ltd., entering the biotech sector focused on microbiological detection and molecular biology products. It remains primarily a retail operation with new interests in laboratory diagnostics.

Industry: Non-Academic Healthcare

Partnerships

Hy Laboratories Ltd.Bank LeumiUnion Group/Horesh family

Beyond the preview

Go deeper on SUPERFARMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SUPERFARMA.

Explore the full profile